MedTrace Logo

Anxiolytic and Analgesic Effects of Melatonin

NCT02386319 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2021-09-02

Study results available
· View outcomes & findings →

Summary

The study's main objective is to investigate melatonin's anxiolytic and sleep-regulating effects in patients undergoing surgery. Moreover, the investigators intend to investigate the pharmacokinetic parameters of melatonin in this patient population.

Conditions

Interventions

DRUG

Melatonin

Gelatin capsules

DRUG

Placebo

Placebo capsules

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Dennis B Zetner, MD. · Herlev Hospital, Herlev Ringvej 75, Herlev, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2021-03-31
Completion
2021-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02386319 on ClinicalTrials.gov